Emcure Pharmaceuticals Limited (BOM:544210)
India flag India · Delayed Price · Currency is INR
1,515.95
+32.50 (2.19%)
At close: Feb 6, 2026

Emcure Pharmaceuticals Statistics

Total Valuation

BOM:544210 has a market cap or net worth of INR 287.34 billion. The enterprise value is 300.22 billion.

Market Cap287.34B
Enterprise Value 300.22B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date Feb 4, 2026
Ex-Dividend Date Aug 14, 2025

Share Statistics

Current Share Class 189.57M
Shares Outstanding n/a
Shares Change (YoY) +2.49%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 72.80%
Owned by Institutions (%) 4.99%
Float 25.12M

Valuation Ratios

The trailing PE ratio is 33.03 and the forward PE ratio is 26.10.

PE Ratio 33.03
Forward PE 26.10
PS Ratio 3.25
PB Ratio 5.88
P/TBV Ratio 7.70
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 34.51
EV / Sales 3.39
EV / EBITDA 17.56
EV / EBIT 23.32
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.34
Debt / EBITDA 0.97
Debt / FCF n/a
Interest Coverage 14.20

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 15.83%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 13.15M
Profits Per Employee 1.29M
Employee Count6,731
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BOM:544210 has paid 3.12 billion in taxes.

Income Tax 3.12B
Effective Tax Rate 25.84%

Stock Price Statistics

The stock price has increased by +21.33% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +21.33%
50-Day Moving Average 1,456.27
200-Day Moving Average 1,353.22
Relative Strength Index (RSI) 53.99
Average Volume (20 Days) 12,658

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:544210 had revenue of INR 88.50 billion and earned 8.70 billion in profits. Earnings per share was 45.90.

Revenue88.50B
Gross Profit 52.28B
Operating Income 12.87B
Pretax Income 12.07B
Net Income 8.70B
EBITDA 16.63B
EBIT 12.87B
Earnings Per Share (EPS) 45.90
Full Income Statement

Balance Sheet

The company has 5.12 billion in cash and 16.59 billion in debt, with a net cash position of -11.47 billion.

Cash & Cash Equivalents 5.12B
Total Debt 16.59B
Net Cash -11.47B
Net Cash Per Share n/a
Equity (Book Value) 48.84B
Book Value Per Share 250.31
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.07%, with operating and profit margins of 14.55% and 9.83%.

Gross Margin 59.07%
Operating Margin 14.55%
Pretax Margin 13.63%
Profit Margin 9.83%
EBITDA Margin 18.79%
EBIT Margin 14.55%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.20%.

Dividend Per Share 3.00
Dividend Yield 0.20%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -2.49%
Shareholder Yield -2.29%
Earnings Yield 3.03%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1